C12N 2770/32032
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2770/32032 (Use of virus as therapeutic agent, other than vaccine) appears on 7 US grants and 22 published applications in this corpus.
Search patents in C12N- Granted patents
- 7
- Published applications
- 22
- Assignees
- 12
- Inventors
- 40
- Latest grant
- 23 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 1 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 1 |
| 2014 | 1 | 1 |
| 2015 | 0 | 1 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 2 |
| 2021 | 0 | 1 |
| 2022 | 0 | 4 |
| 2023 | 0 | 0 |
| 2024 | 0 | 3 |
| 2025 | 2 | 2 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Second generation Seneca Valley virus oncolytic therapy: compositions and methods thereof23 Dec 2025US 12,502,414 B2Seneca Therapeutics, Inc.
- Oncolytic virus expressing a car T cell target and uses thereof22 Jul 2025US 12,364,724 B2City of Hope
- Gene-modified coxsackievirus18 Sep 2018US 10,076,547 B2Kyushu University, National University Corporation
- Seneca valley virus based compositions and methods for treating disease17 Jun 2014US 8,753,622 B2Novartis AG
- Methods and compositions for treatment of hematologic cancers7 Aug 2012US 8,236,298 B2Viralytics Limited
- Intracellular Delivery of Therapeutic Cargos and Viral RNAS by Engineered Salmonella17 Sep 2026US 2026/0272995 A1The Trustees of Columbia University in the City of New York
- Oncolytic Viruses as Therapeutic Agents for Treating Cancer6 Aug 2026US 2026/0226426 A1ImmVirX Pty Ltd
- Oncolytic virus expressing a car t cell target and uses thereof18 Dec 2025US 2025/0381237 A1City of Hope
- Production of rna polynucleotides encoding picornavirus11 Sep 2025US 2025/0281556 A1ElevateBio Technologies, Inc.
- Compositions and methods of seneca valley virus (svv) related cancer therapy28 Nov 2024US 2024/0390439 A1
Most cited
By later US patents
- Seneca Valley virus based compositions and methods for treating disease5US 7,638,318 B2Norvartis AG · 2009
- Seneca Valley virus based compositions and methods for treating disease4US 8,039,606 B2Novartis AG · 2011
- Seneca valley virus based compositions and methods for treating disease3US 8,753,622 B2Novartis AG · 2014
- Gene-modified coxsackievirus1US 10,076,547 B2Kyushu University, National University Corporation · 2018
- Methods and compositions for treatment of hematologic cancers1US 8,236,298 B2Viralytics Limited · 2012